Community spread of extended-spectrum β-lactamase-producing bacteria detected in social insurance hospitals throughout Japan

Journal of Infection and Chemotherapy

Volumn 22, Issue 6, 2016, Pages 395-399

  Shibasaki, Mayumi ^a   Komatsu, Masaru ^b   Sueyoshi, Noriyuki ^c   Maeda, Misaho ^d   Uchida, Takae ^e   Yonezawa, Hitoshi ^f   Inagaki, Kenji ^g   Omi, Ayako ^a   Matsumoto, Hidenobu ^h   Murotani, Makiko ^a   Iwamoto, Tsukasa ^g   Kodaka, Yoshihiro ⁱ   Kieda, Hideto ⁱ   Tokiwa, Manabu ^j   Masuwa, Bunji ^k   Kinoshita, Mari ^l   Saito, Kazuei ^m   Katou, Masahiko ⁱ  

^a KYUSHU HOSPITAL   (Japan)

^b TENRI HEALTH CARE UNIVERSITY   (Japan)

^c National Hospital Organization   (Japan)

^d HOSHIGAOKA KOSEINENKIN HOSPITAL   (Japan)

^e SAITAMA MEDICAL CENTER   (Japan)

^f Joto Hospital   (Japan)

^g CHUKYO HOSPITAL   (Japan)

^h JCHO Hokkaido Hospital   (Japan)

ⁱ JCHO Yokkaichi Hazu Medical Center   (Japan)

^j JCHO Ritsurin Hospital   (Japan)

^k JCHO Isahaya General Hospital   (Japan)

^l JCHO Kumamoto General Hospital   (Japan)

^m Japan Community Healthcare Organization Sendai Hospital   (Japan)

more..

Author keywords

Enterobacteriaceae; ESBL; PCR; Surveillance

Indexed keywords

ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATION; COMMUNITY ACQUIRED INFECTION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA OXYTOCA; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCTIN PROTEUS MIRABILIS; GENOTYPE; HOSPITAL INFECTION; HUMAN; JAPAN; KLEBSIELLA OXYTOCA; NONHUMAN; PROTEUS MIRABILIS; SOCIAL INSURANCE; ADULT; AGED; BIOSYNTHESIS; CHILD; COMMUNITY HOSPITAL; DNA FINGERPRINTING; ENTEROBACTERIACEAE; ENZYMOLOGY; GENETICS; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; SOCIAL SECURITY; VERY ELDERLY; YOUNG ADULT;

BETA LACTAMASE;

ADULT; AGED; AGED, 80 AND OVER; BETA-LACTAMASES; CHILD; COMMUNITY-ACQUIRED INFECTIONS; DNA FINGERPRINTING; ENTEROBACTERIACEAE; GENOTYPE; HOSPITALS, COMMUNITY; HUMANS; INFANT; JAPAN; MIDDLE AGED; SOCIAL SECURITY; YOUNG ADULT;

EID: 84966309428     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1016/j.jiac.2016.03.001     Document Type: Article

References (19)

1. Bush K., Jacoby G.A., Medeiros A.A. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995, 9:1211-1233.
2. Norskow-Lauritsen N., Marchandin H., Dowzicky M.J. Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007). Int J Antimicrob Agents 2009, 34:121-130.
3. Hirakata Y., Matsuda J., Miyazaki Y., Kamihira S., Kawakami S., Miyazawa Y., et al. Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002). Diagn Microbiol Infect Dis 2005, 52:323-329.
4. Muratani T., Matsumoto T. Urinary tract infection caused by fluoroquinolone- and cephem-resistant Enterobacteriaceae. Int J Antimicrob Agents 2006, 28S:S10-S13.
5. Paterson D.L., Bonomo R.A. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev 2005, 18:657-686.
6. Cantón R., Couque T.M. The CTX-M β-lactamase pandemic. Curr Opin Microbiol 2006, 9:466-475.
7. Suzuki S., Shibata N., Yamane K., Wachino J., Ito K., Arakawa Y. Change in the prevalence of extended-spectrum-beta-lactamase-producing Escherichia coli in Japan by clonal spread. J Antimicrob Chemother 2009, 63:72-79.
8. Nakamura T., Komatsu M., Yamasaki K., Fukuda S., Miyamoto Y., Higuchi T., et al. Epidemiology of Escherichia coli, Klebsiella species, and Proteus mirabilis strains producing extended-spectrum β-lactamases from clinical samples in the Kinki Region of Japan. Am J Clin Pathol 2012, 137:620-626.
9. Clinical and Laboratory Standards Institute Document M100-S22. Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement 2012, Clinical and Laboratory Standards Institute, Wayne, PA.
10. Jarlier V., Nicolas M.H., Fournier G., Philippon A. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988, 10:867-878.
11. Nishio H., Komatsu M., Shibata N., Shimakawa K., Sueyoshi N., Ura T., et al. Metallo-beta-lactamase-producing gram-negative bacilli: laboratory-based surveillance in cooperation with 13 clinical laboratories in the Kinki region of Japan. J Clin Microbiol 2004, 42:5256-5263.
12. Versalovic J., Koeuth T., Lupski J.R. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res 1991, 19:6823-6831.
13. Siegel J.D., Rhinehart E., Jackson M., Chiarello L. CDC Management of Multidrug-resistant Organisms in Healthcare Settings 2006, http://www.cdc.gov/hicpac/pdf/guidelines/MDROGuideline2006.pdf.
14. Onodera N., Yamada Y., Sakurai S., Suzuki K., Suwabe A. Isolation conditions for extended-spectrum β-lactamase-producing bacteria: analysis of differing characteristics and causes of isolation conditions at two facilities. Jpn J Chemother 2012, 60:553-559.
15. Shibata N., Kurokawa H., Doi Y., Yagi T., Yamane K., Wachino J., et al. PCR classification of CTX-M-type beta-lactamase genes identified in clinically isolated gram-negative bacilli in Japan. Antimicrob Agents Chemother 2006, 50:791-795.
16. Nakamura T., Komatsu M., Shimakawa K., Sueyoshi N., Satoh K., Toyokawa M., et al. Extended-spectrum-beta-lactamase-producing Proteus mirabilis: laboratory-based surveillance in cooperation with 12 clinical laboratories in the Kinki Region of Japan. Kansenshogaku Zasshi 2006, 80:231-237.
17. Ishihara T., Furukawa I., Kuroki T., Kamiyama T. Isolation of extended-spectrum β-lactamase-producing bacteria from retail chicken meat and diarrhea patients at community hospitals. Jpn J Food Microbiol 2011, 28:123-127.
18. Hibino S., Fukuchi K., Abe Y., Hoshino A., Sakurai S., Mikawa T., et al. Four infants with upper urinary tract infection due to extended-spectrum β-lactamase (ESBL)-producing Escherichia coli. Kansenshogaku Zasshi 2011, 85:481-487.
19. Niki M., Hirai I., Yoshinaga A., Ulzii-Orshikh L., Nakata A., Yamamoto A., et al. Extended-spectrum β-lactamase-producing Escherichia coli strains in the feces of carriers contribute substantially to urinary tract infections in these patients. Infection 2011, 39:467-471.